We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-4.11%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.1B
AUM Growth
-$238M
Cap. Flow
-$59.4M
Cap. Flow %
-1.92%
Top 10 Hldgs %
43.18%
Holding
179
New
2
Increased
27
Reduced
96
Closed
7

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$22.8M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.48M
3
OWL icon
Blue Owl Capital
OWL
+$2.82M
4
SHW icon
Sherwin-Williams
SHW
+$1.87M
5
HLT icon
Hilton Worldwide
HLT
+$1.76M

Top Sells

Rank Stock Value
1
CAE icon
CAE Inc. Common Shares
CAE
+$53.2M
2
BKI
Black Knight, Inc. Common Stock
BKI
+$10.6M
3
WMS icon
Advanced Drainage Systems
WMS
+$6.74M
4
LUMN icon
Lumen
LUMN
+$3M
5
APO icon
Apollo Global Management
APO
+$2.78M

Sector Composition

Rank Sector Weight
1 Financials 38.96%
2 Healthcare 14.34%
3 Technology 13.21%
4 Communication Services 8.71%
5 Industrials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGI icon
151
Alamos Gold
AGI
$12B
$148K ﹤0.01%
20,000
– –
TMM
152
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$133K ﹤0.01%
238,233
– –
VTRS icon
153
Viatris
VTRS
$20.8B
$91K ﹤0.01%
10,699
– –
VRCA icon
154
Verrica Pharmaceuticals
VRCA
$89M
$88K ﹤0.01%
3,000
– –
AMRN
155
Amarin Corp
AMRN
$297M
$33K ﹤0.01%
1,500
– –
RIG icon
156
Transocean
RIG
$5.48B
$29K ﹤0.01%
11,600
– –
AGFS
157
DELISTED
AgroFresh Solutions Inc
AGFS
$20K ﹤0.01%
13,576
– –
BA icon
158
Boeing
BA
$169B
– –
-1,594
Closed -$218K
EMR icon
159
Emerson Electric
EMR
$81.6B
– –
-3,000
Closed -$239K
HELE icon
160
Helen of Troy
HELE
$656M
– –
-3,500
Closed -$568K
SDY icon
161
State Street SPDR S&P Dividend ETF
SDY
$22.1B
– –
-2,467
Closed -$293K
TEVA icon
162
CALL
Teva Pharmaceuticals
TEVA
$40.4B
– –
-7,350
Closed -$2.15M
VWO icon
163
Vanguard FTSE Emerging Markets ETF
VWO
$117B
– –
-4,905
Closed -$204K
WBA
164
DELISTED
Walgreens Boots Alliance
WBA
– –
-6,485
Closed -$246K
ESTRW
165
DELISTED
Estre Ambiental, Inc
ESTRW
$0 ﹤0.01%
218,598
-400
-0.2% –
VCMP
166
DELISTED
VCAMPUS CORP
VCMP
$0 ﹤0.01%
59,956
– –
3 4 5 6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2022 Portfolio in Review

As of Q3 2022, Beck Mack & Oliver held 179 positions worth $3.1B, down 7.1% from $3.33B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Beck Mack & Oliver's Q3 2022 filing shows 2 new, 27 increased, 96 reduced and 7 closed positions. Its largest new stake was HCA Healthcare: 1,095 shares worth $201K. The largest sale was CAE Inc. Common Shares, an estimated $53.2M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2022 buy was HCA Healthcare: 1,095 shares worth $201K.
  • Beck Mack & Oliver added most to Ferguson in Q3 2022, an estimated $22.8M increase.
  • Beck Mack & Oliver's biggest Q3 2022 reduction was CAE Inc. Common Shares, cutting an estimated $53.2M.
  • Beck Mack & Oliver fully exited Helen of Troy in Q3 2022, selling an estimated $568K.
  • Beck Mack & Oliver's ten largest holdings make up 43% of its $3.1B portfolio in Q3 2022.
  • Beck Mack & Oliver opened 2 new positions and closed 7 in Q3 2022.
  • Beck Mack & Oliver's portfolio value fell 7.1% quarter-over-quarter to $3.1B.

Based on Beck Mack & Oliver's 13F filing for Q3 2022, filed 10 Nov 2022.